Destruction stacking optimization, biopsy bundling accuracy, and Mohs surgery coding built for dermatology — so every claim reflects the care you delivered.
Dermatology billing involves strict destruction code stacking limits where payers cap the number of lesion destructions billable per session. Biopsy bundling rules vary significantly by payer — some bundle biopsies with E/M visits, others don't. Mohs micrographic surgery requires stage-by-stage coding with specimen block documentation. Cosmetic vs. medical procedure classification must be airtight to avoid medical necessity denials.
Dermatology practices with high-complexity procedures — Mohs surgery, extensive excisions, and multi-lesion sessions — have significant OON upside. REL1EF's dedicated negotiation layer recovers up to 6× Medicare rates on dermatology OON claims that payer vendors routinely reprice to a fraction of billed charges.
Dermatology claims live and die on lesion specifics. Excision codes (benign 11400–11446, malignant 11600–11646) are chosen by anatomic site and lesion diameter including margins — measured before excision — so an undocumented size or margin downcodes the claim. Destruction of premalignant lesions (17000, add-on 17003, 17004) and benign destruction (17110/17111) carry strict counting rules. Mohs surgery (17311–17315) is billed by stage and tissue block, and the surgeon must also serve as the pathologist — payers deny when documentation doesn't support both roles.
Modifier 25 is the most-scrutinized modifier in dermatology: appending it to a separate E/M on the same day as a procedure such as a biopsy is correct only when the visit is significant and separately identifiable, and major payers have rolled out automatic reductions and audits targeting it. Biopsy codes (11102–11107) and the associated pathology (88305) must be linked correctly, and modifier 59/XS distinguishes distinct lesions. The cosmetic-versus-medically-necessary determination decides whether a service is billable to insurance at all.
REL1EF codes to documented lesion size, site, and pathology, defends modifier 25/59 with the record, and separates cosmetic from covered services cleanly. On the denial side we target the patterns that drain derm A/R: medical-necessity edits on destructions, mismatched biopsy-to-pathology linkage, and modifier-25 auto-reductions — appealing with documentation rather than resubmitting blind.
Start with the free A/R recovery trial to see our work firsthand — or contact us directly about dermatology billing services.
Common questions about dermatology billing, destruction stacking, and Mohs surgery coding.
Start Free A/R Trial